Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BioDrugs
Metadata
Title
Managing the Neuropsychiatric Adverse Effects of Interferon Treatment
Author
Dr Alan D. Valentine
Publication date
01-04-1999
Publisher
Springer International Publishing
Published in
BioDrugs / Issue 4/1999
Print ISSN: 1173-8804
Electronic ISSN: 1179-190X
DOI
https://doi.org/10.2165/00063030-199911040-00002

Other articles of this Issue 4/1999

BioDrugs 4/1999 Go to the issue

Review Article

Guidelines for the Optimal Use of Muromonab CD3 in Transplantation

Disease Management

Monitoring Antitumour Immune Response During Immunotherapy of Cancer

Original Research Article

Fish Oil Treatment of Interferon-Alpha-Induced Dyslipidaemia

Review Article

Thrombopoietin

Leading Article

Influenza Vaccination and Asthma

Review Article

Cancer Immunotherapy